.Pharmacolibrary.Drugs.ATC.N.N06AB06 .Pharmacolibrary.Drugs.ATC.N.N06AB06| name: | Sertraline |
| ATC code: | N06AB06 | route: | oral |
| n-compartments | 2 |
Sertraline is a selective serotonin reuptake inhibitor (SSRI) antidepressant indicated for the treatment of major depressive disorder, obsessive-compulsive disorder, panic disorder, post-traumatic stress disorder, social anxiety disorder, and premenstrual dysphoric disorder. It is widely approved and used today in adults and pediatric patients for certain indications.
Pharmacokinetic parameters reported for healthy adult volunteers after oral administration of sertraline tablets.
Alhadab, AA, & Brundage, RC (2020). Population Pharmacokinetics of Sertraline in Healthy Subjects: a Model-Based Meta-analysis. The AAPS journal 22(4) 73–None. DOI:10.1208/s12248-020-00455-y PUBMED:https://pubmed.ncbi.nlm.nih.gov/32430638
Zang, YN, et al., & Ruan, CJ (2024). Population pharmacokinetics of olanzapine in pediatric patients with psychiatric disorders. Expert opinion on drug metabolism & toxicology 20(8) 827–840. DOI:10.1080/17425255.2024.2380472 PUBMED:https://pubmed.ncbi.nlm.nih.gov/39010781
Wang, JH, et al., & Zhou, HH (2001). Pharmacokinetics of sertraline in relation to genetic polymorphism of CYP2C19. Clinical pharmacology and therapeutics 70(1) 42–47. DOI:10.1067/mcp.2001.116513 PUBMED:https://pubmed.ncbi.nlm.nih.gov/11452243